indazoles has been researched along with Hypertension, Renal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeva, S; Basgen, JM; Castonguay, P; Clark, AR; Dubois, F; Dvela-Levitt, M; Garrett, MR; Greka, A; Hoffmann, SC; Hopkins, CR; Johnson, AC; Jung, JY; Kim, S; Lander, ES; Montesinos, MS; Reichardt, J; Sidhom, EH; Sieber, J; Weins, A; Wieder, N; Zhou, Y | 1 |
| Bindels, RJM; van der Wijst, J | 1 |
2 other study(ies) available for indazoles and Hypertension, Renal
| Article | Year |
|---|---|
A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
Topics: Animals; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Indazoles; Mutation; Podocytes; Proteinuria; rac1 GTP-Binding Protein; Rats; Rats, Inbred Dahl; Rats, Transgenic; Small Molecule Libraries; TRPC Cation Channels | 2017 |
Renal physiology: TRPC5 inhibition to treat progressive kidney disease.
Topics: Animals; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Indazoles; Mutation; Podocytes; Proteinuria; rac1 GTP-Binding Protein; Rats; Rats, Inbred Dahl; Rats, Transgenic; Small Molecule Libraries; TRPC Cation Channels | 2018 |